target-drug-asset-bp

Supports evaluation of translational potential for target-based drug research outcomes and preparation of asset business plans (BP). Applicable to organizing targets/drug findings from universities, hospitals, or research institutions into translational maturity, intellectual property, competitive landscape, partner matching, and asset BPs.